510(k) Report

510(k) · Cleared

Cleared

Antimicrobial Ultrasite Value, Ultrasite AG

K073396510(k) TraditionalCleared Aug 7, 2008248-day reviewClass II21 CFR 880.5440

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

B.Braun Medical, Inc. · FPA Set, Administration, Intravascular

Cleared on Aug 7, 2008 as substantially equivalent to K955585 (B.Braun Medical, Inc., 1996) and 1 other predicate after a 248-day review. Its family tree reaches back 3 generations to 1986.

Decided
Aug 7, 2008
Review
248 days
Class
Class II
Product code
FPA
Recalls
None
Predicates
2

Its longest line of descent runs back 3 generations to K861563 (1986). 7 ancestors in all, the oldest K862691 (1986). No later device cites it as a predicate yet.

Other ancestors, by year cleared 1996: 1 other ancestor2002: 1 other ancestor1995: 1 other ancestor1986: 1 other ancestorK861563 · Vitaguard Percutaneous Infection Control Kit · Vitaphore Corp. · 1986K954970 · Stopcock & Luer Lock Plug · Medex, Inc. · 1996 · recalledK053405 · Bacstop · Elcam Medical Acal · 2006198519901995200020052010
Other ancestors, by generation 1 generation back: 1 other ancestor2 generations back: 2 other ancestors3 generations back: 1 other ancestor K053405 · Bacstop · Elcam Medical Acal · 2006K954970 · Stopcock & Luer Lock Plug · Medex, Inc. · 1996 · recalledK861563 · Vitaguard Percutaneous Infection Control Kit · Vitaphore Corp. · 19860
  1. Root · 3 generations backK861563 Vitaguard Percutaneous Infection Control KitVitaphore Corp. · 1986
  2. 2 generations backK954970 Stopcock & Luer Lock PlugMedex, Inc. · 1996 · Recalled
  3. 1 generation backK053405 BacstopElcam Medical Acal · 2006
  4. This deviceK073396 Antimicrobial Ultrasite Value, Ultrasite AGB.Braun Medical, Inc. · 2008
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−3K861563Vitaguard Percutaneous Infection Control KitVitaphore Corp.1986—
−2K954970Stopcock & Luer Lock PlugMedex, Inc.19961
−1K053405BacstopElcam Medical Acal2006—
0 (this device)K073396Antimicrobial Ultrasite Value, Ultrasite AGB.Braun Medical, Inc.2008—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
198610
199510
199610
200210
FIG. 1 — Lineage of K073396, 1986–2008Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in FPA? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new FPA device

  1. #1 K243841 Sparta Infusion Set for Insulinscore 13.4 · 3 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (2)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K955585V2 Injection Site
Summary page 1
…Class II, Product Code FPA, Intravascular Administration Set, 21 CFR 880.5440 PREDICATE DEVICES: B. Braun Medical Inc. Ultrasite Valve 510(k) K955585 Elcam Medical Antimicrobial Stopcock 510(k) K053405 DESCRIPTION: B. Braun's Antibacterial Ultrasite® Valv…
B.Braun Medical, Inc.199627
*K053405Bacstop
Summary page 1
…CFR 880.5440 PREDICATE DEVICES: B. Braun Medical Inc. Ultrasite Valve 510(k) K955585 Elcam Medical Antimicrobial Stopcock 510(k) K053405 DESCRIPTION: B. Braun's Antibacterial Ultrasite® Valve is an individually packaged, sterile, non-pyrogeni…
Elcam Medical Acal2006—

Also cleared against K955585: 6 other devices →

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 22 years and passes through 4 companies; a new generation was cleared every 9.7 years on median.
  • 4 of the 7 ancestors have a recall of any class.
  • 6 other devices also cite its predicate K955585.

How does its category compare?

All FPA devices

FPA Set, Administration, Intravascular: FDA decisions, review times, recalls and adverse event reports over 20 years. 2008, this device’s year, is highlighted.

FDA decisions per year · FPA

11in 2025

2007: 162008: 182009: 102010: 232011: 122012: 212013: 132014: 222015: 172016: 122017: 172018: 42019: 72020: 102021: 132022: 142023: 142024: 72025: 112026 (partial year): 5
2007high 23 (2010) · low 4 (2018)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · FPA

225in 2025

2007: 75 days median2008: 89 days median2009: 166 days median2010: 120 days median2011: 87 days median2012: 96 days median2013: 90 days median2014: 89 days median2015: 123 days median2016: 195 days median2017: 240 days median2018: 177 days median2019: 161 days median2020: 327 days median2021: 186 days median2022: 213 days median2023: 340 days median2024: 244 days median2025: 225 days median2026 (partial year): 266 days median
2007high 340 (2023) · low 75 (2007)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · FPA

98in 2025

2007: 172008: 152009: 1662010: 582011: 282012: 16, 4 Class I2013: 642014: 242015: 62016: 102017: 132018: 42019: 132020: 1072021: 12022: 9, 5 Class I2023: 12, 4 Class I2024: 13, 1 Class I2025: 98, 1 Class I2026 (partial year): 10, 2 Class I
2007high 166 (2009) · low 1 (2021)2026

Class I (17 since 2007) Class II/III not classified

Adverse event reports per year · FPA

34,506in 2025

2007: 1,4992008: 1,9412009: 2,5122010: 2,5372011: 4,4072012: 4,9302013: 4,6512014: 4,6952015: 6,6252016: 8,4702017: 6,4622018: 6,5742019: 11,2272020: 9,5632021: 10,4142022: 13,3932023: 10,9162024: 47,2102025: 34,506
2007high 47,210 (2024) · low 1,499 (2007)2025

MAUDE reports naming product code FPA, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20071675171,499
20081889151,941
2009101661662,512
201023120582,537
20111287284,407
2012219616 (4)4,930
20131390644,651
20142289244,695
20151712366,625
201612195108,470
201717240136,462
2018417746,574
201971611311,227
2020103271079,563
202113186110,414
2022142139 (5)13,393
20231434012 (4)10,916
2024724413 (1)47,210
20251122598 (1)34,506
2026526610 (2)—

What is it indicated for?

The B. Braun Antibacterial Ultrasite Valve (Ultrasite Ag) is intended for aspiration, injection or gravity/pump flow of IV fluids upon insertion of a male luer fitting. Not intended for use with power injectors.

The Antibacterial Ultrasite Valve contains a silver based compound which may help to reduce bacterial growth on the surface and within the fluid path of the device.

Testing with Ultrasite Ag Valve demonstrated antibacterial effectiveness against Pseudomonas aeruginosa,Kebsiella pneumoniae,and Enterobacteraerogenes over 96 hours.

The Antibacterial Ultrasite Valve is not intended for use in the treatment of existing infections.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K073396: Antimicrobial Ultrasite Value, Ultrasite AG.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 4, 2026. https://510kreport.com/device/K073396

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026